Skip to content

aTYR PHARMA INC

ATYR· NasdaqCore metricsCIK 1339970

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -8.45%
Market cap
$16.29M
2.55M shares
Filings
756
$0.00
Q3 2026−19.1% FY25 yoy
-$18.26M
Q3 2026N/M FY25 yoy
-$18.79M
Q3 2026N/M FY25 yoy
-$31.64M
Q3 2026derivedN/M FY25 yoy
-$7.43
Q3 2026N/M FY25 yoy
$13.14M
Q3 2026−2.8% FY25 yoy
$16.29M
—
85.7×
0.5×
-381.00%
—

FY2025 figures · derived

Price

$6.39+711.02%+$5.60past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$190.00KFY 2025
$10.46M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$190,000reported
FY 20242024-12-31$235,000reported
FY 20232023-12-31$353,000reported
FY 20222022-12-31$10,386,000reported
FY 20212021-12-31$0reported
FY 20202020-12-31$10,455,000reported
FY 20192019-12-31$422,000reported

Segments

Products
Revenue by Products, FY2019 to FY2025FY2019License Revenues · FY2019 · $422.00KFY2020License Revenues · FY2020 · $10.46MLicense and Collaboration Revenues · FY2020 · $10.46MFY2022Collaboration Revenue · FY2022 · $10.00MAdditional Collaboration Revenue · FY2022 · $400.00KCollaboration Revenue · FY2022 · $10.00MLicense and Collaboration Revenues · FY2022 · $10.39MFY2023Collaboration Revenue · FY2023 · $400.00KAdditional Collaboration Revenue · FY2023 · $400.00KFY2024Collaboration Revenue · FY2024 · $200.00KFY2025Collaboration Revenue · FY2025 · $200.00K
LineFY2025ShareChange
Collaboration Revenue$200.00K105%±0.0%
Additional Collaboration Revenue———
Collaboration Revenue———
License Revenues———
License and Collaboration Revenues———
Total$190.00K

From the 10-K filed Mar 5, 2026ATYR

Biological products, except diagnostic substances

aTYR PHARMA INC is the 83rd largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR